Patent ID: 6468993
Filing Date: 2002-10-22
Classification: A61K

Abstract:
A method of reducing the risk of a patient developing osteoporosis, said method comprising administering an effective amount to a patient in need thereof of a compound of formula I: wherein:R1 is hydrogen, lower alkyl or R2 and R4 are each individually SO3âˆ’M+, PO32âˆ’M22+, or PO2S2âˆ’M22+; R3 and R5 are each individually hydrogen, hydroxy or sulfhydryl; m and n are individually 0, 1, 2, 3 or 4, with the proviso that if m or n is 0, then R3 is hydrogen; and M is hydrogen or an alkali metal ion; or a pharmaceutically acceptable salt thereof.